These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19001871)

  • 1. Identification of beta-catenin as a novel substrate of Polo-like kinase 1.
    Arai T; Haze K; Iimura-Morita Y; Machida T; Iida M; Tanaka K; Komatani H
    Cell Cycle; 2008 Nov; 7(22):3556-63. PubMed ID: 19001871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cotargeting Polo-Like Kinase 1 and the Wnt/β-Catenin Signaling Pathway in Castration-Resistant Prostate Cancer.
    Li J; Karki A; Hodges KB; Ahmad N; Zoubeidi A; Strebhardt K; Ratliff TL; Konieczny SF; Liu X
    Mol Cell Biol; 2015 Dec; 35(24):4185-98. PubMed ID: 26438599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nek2 phosphorylates and stabilizes β-catenin at mitotic centrosomes downstream of Plk1.
    Mbom BC; Siemers KA; Ostrowski MA; Nelson WJ; Barth AI
    Mol Biol Cell; 2014 Apr; 25(7):977-91. PubMed ID: 24501426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NFBD1/MDC1 is phosphorylated by PLK1 and controls G2/M transition through the regulation of a TOPOIIα-mediated decatenation checkpoint.
    Ando K; Ozaki T; Hirota T; Nakagawara A
    PLoS One; 2013; 8(12):e82744. PubMed ID: 24349352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional independency between catalytic activity and subcellular targeting of polo-like kinase-1: phenotypes of ectopic overexpression of various mutants.
    Ji JH; Jang YJ
    Cell Cycle; 2008 Jun; 7(11):1597-603. PubMed ID: 18560274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of rictor as a novel substrate of Polo-like kinase 1.
    Shao T; Liu X
    Cell Cycle; 2015; 14(5):755-60. PubMed ID: 25714006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B23/nucleophosmin serine 4 phosphorylation mediates mitotic functions of polo-like kinase 1.
    Zhang H; Shi X; Paddon H; Hampong M; Dai W; Pelech S
    J Biol Chem; 2004 Aug; 279(34):35726-34. PubMed ID: 15190079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
    Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR
    Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P21-activated kinase is required for mitotic progression and regulates Plk1.
    Maroto B; Ye MB; von Lohneysen K; Schnelzer A; Knaus UG
    Oncogene; 2008 Aug; 27(36):4900-8. PubMed ID: 18427546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of potential Plk1 targets in a cell-cycle specific proteome through structural dynamics of kinase and Polo box-mediated interactions.
    Bibi N; Parveen Z; Rashid S
    PLoS One; 2013; 8(8):e70843. PubMed ID: 23967120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of Vimentin Phosphorylation by the Avian Reovirus p17 through Inhibition of CDK1 and Plk1 Impacting the G2/M Phase of the Cell Cycle.
    Chiu HC; Huang WR; Liao TL; Wu HY; Munir M; Shih WL; Liu HJ
    PLoS One; 2016; 11(9):e0162356. PubMed ID: 27603133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of β-catenin Ser60 by polo-like kinase 1 drives the completion of cytokinesis.
    Yu JE; Kim SO; Hwang JA; Hong JT; Hwang J; Soung NK; Cha-Molstad H; Kwon YT; Kim BY; Lee KH
    EMBO Rep; 2021 Dec; 22(12):e51503. PubMed ID: 34585824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plk3 phosphorylates topoisomerase IIalpha at Thr(1342), a site that is not recognized by Plk1.
    Iida M; Matsuda M; Komatani H
    Biochem J; 2008 Apr; 411(1):27-32. PubMed ID: 18062778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Genetic Toggle for Chemical Control of Individual Plk1 Substrates.
    Johnson JM; Hebert AS; Drane QH; Lera RF; Wan J; Weaver BA; Coon JJ; Burkard ME
    Cell Chem Biol; 2020 Mar; 27(3):350-362.e8. PubMed ID: 32017920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calmodulin activation of polo-like kinase 1 is required during mitotic entry.
    Dai G; Qian Y; Chen J; Meng FL; Pan FY; Shen WG; Zhang SZ; Xue B; Li CJ
    Biochem Cell Biol; 2013 Oct; 91(5):287-94. PubMed ID: 24032677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic identification of Hsp70 as a new Plk1 substrate in arsenic trioxide-induced mitotically arrested cells.
    Chen YJ; Lin YP; Chow LP; Lee TC
    Proteomics; 2011 Nov; 11(22):4331-45. PubMed ID: 21887822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polo-like kinase 1 phosphorylation of p150Glued facilitates nuclear envelope breakdown during prophase.
    Li H; Liu XS; Yang X; Song B; Wang Y; Liu X
    Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14633-8. PubMed ID: 20679239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TTDN1 is a Plk1-interacting protein involved in maintenance of cell cycle integrity.
    Zhang Y; Tian Y; Chen Q; Chen D; Zhai Z; Shu HB
    Cell Mol Life Sci; 2007 Mar; 64(5):632-40. PubMed ID: 17310276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer Osaka thyroid (Cot) phosphorylates Polo-like kinase (PLK1) at Ser137 but not at Thr210.
    Wu B; Jiang P; Mu Y; Wilmouth RC
    Biol Chem; 2009 Dec; 390(12):1271-7. PubMed ID: 19804365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a consensus motif for Plk (Polo-like kinase) phosphorylation reveals Myt1 as a Plk1 substrate.
    Nakajima H; Toyoshima-Morimoto F; Taniguchi E; Nishida E
    J Biol Chem; 2003 Jul; 278(28):25277-80. PubMed ID: 12738781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.